← FDA DRUG APPROVALS

FDA ANDA · ANDA204635

MOXIFLOXACIN HYDROCHLORIDE

Sponsor: NATCO

APPLICATION
ANDA204635
TYPE
ANDA
ORIGINAL APPROVAL
2015-08-31
LATEST ACTION
2019-12-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MOXIFLOXACIN HYDROCHLORIDEDiscontinued
MOXIFLOXACIN HYDROCHLORIDE EQ 400MG BASE · TABLET · ORAL

Approval history

2019-12-10Labeling · Supplement 3 · standardAP
2019-12-10Labeling · Supplement 1 · standardAP
2019-12-10Labeling · Supplement 6 · standardAP
2019-12-10Labeling · Supplement 4 · standardAP
2015-08-31UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →